Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Geneviève Crouzeix"'
Autor:
Philippe Thuillier, Nathalie Roudaut, Geneviève Crouzeix, Marie Cavarec, Philippe Robin, Ronan Abgral, Véronique Kerlan, Pierre-Yves Salaun
Publikováno v:
Endocrine Connections, Vol 6, Iss 6, Pp 413-421 (2017)
Objective: To evaluate the malignancy rate of focal thyroid incidentaloma (fTI) in a population of patients undergoing a 18F-fluorodeoxyglucose positron emission tomography–computed tomography (FDG PET–CT) for a non-thyroid purpose. Design: We c
Externí odkaz:
https://doaj.org/article/c8c6d865e4db4533b8242025882f2a33
Autor:
Philippe Thuillier, David Bourhis, Nathalie Roudaut, Geneviève Crouzeix, Zarrin Alavi, Ulrike Schick, Philippe Robin, Véronique Kerlan, Pierre-Yves Salaun, Ronan Abgral
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Objective: To evaluate the diagnostic value of FDG PET-CT metabolic parameters and Deauville-like 5 point-scale to predict malignancy in a population of patients presenting focal thyroid incidentaloma (fTI).Design: This retrospective study included 4
Externí odkaz:
https://doaj.org/article/86e6a52473af4c178a03aba508bbd58d
Autor:
Geneviève Crouzeix, Zarrin Alavi, Gilles Quere, Claire Joly, Renaud Descourt, N. Roudaut, Philippe Thuillier, Véronique Kerlan
Publikováno v:
Cancer Immunology, Immunotherapy. 70:2023-2033
The objective of this study was to investigate the association between the onset of TD and treatment efficacy in NSCLC patients who initiated anti-PD-1 blockade (Nivolumab®) and to assess the impact of TD severity and subtype on nivolumab efficacy.
Autor:
Renaud Descourt, Véronique Kerlan, Claire Joly, N. Roudaut, Geneviève Crouzeix, Philippe Thuillier
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Clinical Nuclear Medicine. 43:e310-e311
A 49-year-old man was referred to our department for an assessment of a cerebral metastasis of unknown primary with F-FDG PET/CT. This imaging led to detection of a suspected pulmonary primary carcinoma, as well as an incidental left focal thyroid up
Autor:
Nicolas Aide, Geneviève Crouzeix, Emmanuel Sevin, Stéphane Bardet, Dominique Vaur, Jean-Jacques Michels
Publikováno v:
The Journal of clinical endocrinology and metabolism. 97(9)
Treatment modalities for progressive iodine-refractory poorly differentiated thyroid carcinomas are not yet well defined. Molecular targeted therapy with multikinase inhibitors has recently shown promising results, and cytotoxic chemotherapy is gener